HC Wainwright started coverage on shares of Wave Life Sciences Ltd (NDAQ:WVE) in a research report released on Wednesday, StockTargetPrices.com reports. The firm issued a buy rating and a $41.00 target price on the stock.
Wave Life Sciences (NDAQ:WVE) traded up 0.34% on Wednesday, reaching $29.60. 31,706 shares of the company’s stock were exchanged. The firm has a 50 day moving average of $28.20 and a 200 day moving average of $29.05. Wave Life Sciences has a 12 month low of $8.95 and a 12 month high of $40.15. The stock’s market capitalization is $694.86 million.
“Wave Life Sciences Ltd (WVE) Receives New Coverage from Analysts at HC Wainwright” was first published by sleekmoney and is owned by of sleekmoney. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be accessed at http://sleekmoney.com/wave-life-sciences-ltd-wve-receives-new-coverage-from-analysts-at-hc-wainwright/1662651.html.
About Wave Life Sciences
WAVE Life Sciences Ltd. is a preclinical biopharmaceutical company. The Company focuses on developing its synthetic chemistry platform to develop and commercialize a pipeline of nucleic acid-based therapeutics. It develops nucleic acid therapeutics that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/wave-life-sciences-ltd-wve-receives-new-coverage-from-analysts-at-hc-wainwright/1662651.html
Receive News & Ratings for Wave Life Sciences Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wave Life Sciences Ltd and related companies with MarketBeat.com's FREE daily email newsletter.